Clinical Trials Directory

Trials / Completed

CompletedNCT01892943

Leber Hereditary Optic Neuropathy (LHON) Historical Case Record Survey

Status
Completed
Phase
Study type
Observational
Enrollment
306 (actual)
Sponsor
Santhera Pharmaceuticals · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The objective of this survey is to establish the clinical course of vision loss and recovery in patients with a genetically confirmed diagnosis of Leber Hereditary Optic Neuropathy (LHON). Visual acuity changes over time from onset of symptoms and from visual acuity nadir will be the main endpoint analysed. The survey will collect historically documented visual acuity data for all patients at participating sites with a genetically confirmed diagnosis of LHON. No exclusion criteria apply. Patients are not required to attend the clinic for the survey. Data will be collected in a completely anonymous manner. Ethical approvals and data release agreements will be obtained as required by local regulations.

Conditions

Timeline

Start date
2013-08-01
Primary completion
2014-02-01
Completion
2014-02-01
First posted
2013-07-08
Last updated
2014-05-15

Locations

8 sites across 5 countries: Belgium, Denmark, France, Italy, Slovenia

Source: ClinicalTrials.gov record NCT01892943. Inclusion in this directory is not an endorsement.

Leber Hereditary Optic Neuropathy (LHON) Historical Case Record Survey (NCT01892943) · Clinical Trials Directory